Year |
Citation |
Score |
2019 |
Heijerman HGM, McKone EF, Downey DG, Van Braeckel E, Rowe SM, Tullis E, Mall MA, Welter JJ, Ramsey BW, McKee CM, Marigowda G, Moskowitz SM, Waltz D, Sosnay PR, Simard C, ... ... McCoy KS, et al. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial. Lancet (London, England). PMID 31679946 DOI: 10.1016/S0140-6736(19)32597-8 |
0.309 |
|
2019 |
Goetz D, Kopp BT, Salvator A, Moore-Clingenpeel M, McCoy K, Leung DH, Kloster M, Ramsey BR, Heltshe SH, Borowitz D. Pulmonary findings in infants with cystic fibrosis during the first year of life: Results from the Baby Observational and Nutrition Study (BONUS) cohort study. Pediatric Pulmonology. PMID 30672141 DOI: 10.1002/Ppul.24261 |
0.357 |
|
2019 |
Goss C, Heltshe S, Aitken M, Hornick D, Lechtzin N, McCoy K, Skalland M, Mayer-Hamblett N, Teresi M, Singh P. WS01-3 IV gallium nitrate demonstrates biological activity for chronic Pseudomonas aeruginosa infection in cystic fibrosis Journal of Cystic Fibrosis. 18. DOI: 10.1016/S1569-1993(19)30119-5 |
0.326 |
|
2018 |
Kopp BT, Joseloff E, Goetz D, Ingram B, Heltshe SL, Leung DH, Ramsey BR, McCoy K, Borowitz D. Urinary metabolomics reveals unique metabolic signatures in infants with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 30477895 DOI: 10.1016/J.Jcf.2018.10.016 |
0.342 |
|
2018 |
Robledo-Avila FH, Ruiz-Rosado JD, Brockman KL, Kopp BT, Amer AO, McCoy K, Bakaletz LO, Partida-Sanchez S. Dysregulated Calcium Homeostasis in Cystic Fibrosis Neutrophils Leads to Deficient Antimicrobial Responses. Journal of Immunology (Baltimore, Md. : 1950). PMID 30120123 DOI: 10.4049/Jimmunol.1800076 |
0.364 |
|
2018 |
Sheikh S, Pitts J, Salvator A, Nemastil C, Ulrich L, May A, Mccoy K. Impact Of Race On Long-Term Asthma Control In Children Chest. 154. DOI: 10.1016/J.Chest.2018.08.730 |
0.306 |
|
2017 |
Zemanick ET, Wagner BD, Robertson CE, Ahrens RC, Chmiel JF, Clancy JP, Gibson RL, Harris WT, Kurland G, Laguna TA, McColley SA, McCoy K, Retsch-Bogart G, Sobush KT, Zeitlin PL, et al. Airway microbiota across age and disease spectrum in cystic fibrosis. The European Respiratory Journal. 50. PMID 29146601 DOI: 10.1183/13993003.00832-2017 |
0.416 |
|
2017 |
Freedman S, Orenstein D, Black P, Brown P, McCoy K, Stevens J, Grujic D, Clayton R. Increased Fat Absorption from Enteral Formula Through an In-Line Digestive Cartridge in Patients with Cystic Fibrosis. Journal of Pediatric Gastroenterology and Nutrition. PMID 28471913 DOI: 10.1097/Mpg.0000000000001617 |
0.329 |
|
2016 |
Sheikh S, Handly B, Ryan-Wenger N, Hayes D, Kirkby S, McCoy K, Lind M. Novel CT Scoring System for Sinus Disease in Adults With Cystic Fibrosis Chest. 150: 655A. DOI: 10.1016/J.Chest.2016.08.749 |
0.306 |
|
2016 |
Sheikh S, Handly B, Ryan-Wenger N, Hayes D, Ramanathan C, McCoy K, Lind M. A New CT Scoring System for Sinus Disease in Children With Cystic Fibrosis Chest. 150: 1133A. DOI: 10.1016/J.Chest.2016.08.1243 |
0.346 |
|
2016 |
Sheikh S, Pitts J, Ryan-Wenger N, Stukus D, Kotha K, McCoy K. Impact of Following Asthma Guidelines on Quality of Life of Families With Asthmatic Children: Long-term Follow-up Chest. 150: 960A. DOI: 10.1016/J.Chest.2016.08.1063 |
0.302 |
|
2015 |
Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, Konstan MW, McColley SA, McCoy K, McKone EF, Munck A, et al. Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. The New England Journal of Medicine. 373: 220-31. PMID 25981758 DOI: 10.1056/Nejmoa1409547 |
0.375 |
|
2015 |
Sheikh S, Handly B, Ryan-Wenger N, Kirkby S, Ramanathan C, McCoy K, Hayes D, Lind M. LATE-BREAKING ABSTRACT: A new, easy to use computed tomography based scoring system for sinus disease in cystic fibrosis: Validated with acceptable inter- and intra-rater reliability European Respiratory Journal. 46. DOI: 10.1183/13993003.Congress-2015.Pa3736 |
0.339 |
|
2015 |
Sheikh S, Pitts J, Ryan-Wenger N, Stukus D, McCoy K, Kotha K. Following asthma guidelines improves quality of life in children with asthma European Respiratory Journal. 46. DOI: 10.1183/13993003.Congress-2015.Pa1277 |
0.337 |
|
2015 |
Sheikh S, Pitts J, McCoy K. Asthma guidelines need to be followed at primary care level to improve symptom control in children European Respiratory Journal. 46. DOI: 10.1183/13993003.Congress-2015.Pa1276 |
0.338 |
|
2014 |
Swender DA, Thompson G, Schneider K, McCoy K, Patel A. Osteopathic manipulative treatment for inpatients with pulmonary exacerbations of cystic fibrosis: effects on spirometry findings and patient assessments of breathing, anxiety, and pain. The Journal of the American Osteopathic Association. 114: 450-8. PMID 24917632 DOI: 10.7556/Jaoa.2014.095 |
0.382 |
|
2014 |
Woodley FW, Machado RS, Hayes D, Di Lorenzo C, Kaul A, Skaggs B, McCoy K, Patel A, Mousa H. Children with cystic fibrosis have prolonged chemical clearance of acid reflux compared to symptomatic children without cystic fibrosis. Digestive Diseases and Sciences. 59: 623-30. PMID 24287640 DOI: 10.1007/S10620-013-2950-0 |
0.397 |
|
2013 |
Sheikh S, Pitts J, Ryan-Wenger N, McCoy K. In Children With Family History of Asthma, Does Gender Increase Their Risk for Asthma Chest. 144: 763A. DOI: 10.1378/Chest.1675911 |
0.306 |
|
2013 |
Sheikh S, Ryan-Wenger N, Patel A, McCoy K, Kirkby S. Lobectomy in Cystic Fibrosis Chest. 144: 778A. DOI: 10.1378/Chest.1675846 |
0.382 |
|
2012 |
Kopp BT, Abdulrahman BA, Khweek AA, Kumar SB, Akhter A, Montione R, Tazi MF, Caution K, McCoy K, Amer AO. Exaggerated inflammatory responses mediated by Burkholderia cenocepacia in human macrophages derived from Cystic fibrosis patients. Biochemical and Biophysical Research Communications. 424: 221-7. PMID 22728038 DOI: 10.1016/J.Bbrc.2012.06.066 |
0.334 |
|
2012 |
Hayes D, Kopp B, Mansour H, Kirkby S, Yates A, McCoy K, Daniels C. Exercise-Induced Pulmonary Arterial Hypertension in Pediatric and Young Adult Patients With Cystic Fibrosis Chest. 142: 773A. DOI: 10.1378/Chest.1388349 |
0.317 |
|
2011 |
Kirkby S, Novak K, McCoy K. Aztreonam (for inhalation solution) for the treatment of chronic lung infections in patients with cystic fibrosis: an evidence-based review. Core Evidence. 6: 59-66. PMID 22022288 DOI: 10.2147/Ce.S11181 |
0.418 |
|
2011 |
Abdulrahman BA, Khweek AA, Akhter A, Caution K, Kotrange S, Abdelaziz DH, Newland C, Rosales-Reyes R, Kopp B, McCoy K, Montione R, Schlesinger LS, Gavrilin MA, Wewers MD, Valvano MA, et al. Autophagy stimulation by rapamycin suppresses lung inflammation and infection by Burkholderia cenocepacia in a model of cystic fibrosis. Autophagy. 7: 1359-70. PMID 21997369 DOI: 10.4161/Auto.7.11.17660 |
0.331 |
|
2011 |
Sheikh S, Quach J, McCoy K. Nissen Fundoplication in Patients With Cystic Fibrosis. Impact on Nutrition Chest. 140: 385. DOI: 10.1378/Chest.1114003 |
0.366 |
|
2011 |
Sheikh S, Morris K, McCoy K. In African American Children, Is Socioeconomic Status an Important Factor in Determining Risk for Asthma. A Pilot Study Chest. 140: 3-8. DOI: 10.1378/Chest.1111903 |
0.307 |
|
2011 |
Pitts J, Sheikh S, McCoy K. Omalizumab in Children With Moderate to Severe Allergic Asthma. Our Limited Experience Chest. 140: 3-7. DOI: 10.1378/Chest.1111881 |
0.323 |
|
2011 |
Sheikh S, Quach J, McCoy K. Nissen Fundoplication in Patients With Cystic Fibrosis and Severe GERD. Impact on Lung Disease Chest. 140: 906. DOI: 10.1378/Chest.1107183 |
0.366 |
|
2010 |
Oermann CM, Retsch-Bogart GZ, Quittner AL, Gibson RL, McCoy KS, Montgomery AB, Cooper PJ. An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis. Pediatric Pulmonology. 45: 1121-34. PMID 20672296 DOI: 10.1002/Ppul.21301 |
0.304 |
|
2010 |
Woodley FW, Hayes J, Patel A, McCoy K, Mousa H. T1692 The Association Between Acid Reflux and Cough in Patients With Cystic Fibrosis is Not Dependent on the Type of Acid Reflux Gastroenterology. 138. DOI: 10.1016/S0016-5085(10)62570-X |
0.336 |
|
2009 |
Kirkby S, Novak K, McCoy K. Update on antibiotics for infection control in cystic fibrosis. Expert Review of Anti-Infective Therapy. 7: 967-80. PMID 19803706 DOI: 10.1586/Eri.09.82 |
0.372 |
|
2008 |
McCoy KS, Quittner AL, Oermann CM, Gibson RL, Retsch-Bogart GZ, Montgomery AB. Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 178: 921-8. PMID 18658109 DOI: 10.1164/Rccm.200712-1804Oc |
0.329 |
|
2008 |
Retsch-Bogart GZ, Burns JL, Otto KL, Liou TG, McCoy K, Oermann C, Gibson RL. A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection. Pediatric Pulmonology. 43: 47-58. PMID 18041081 DOI: 10.1002/Ppul.20736 |
0.39 |
|
2008 |
McCoy K, Retsch-Bogart G, Gibson R, Oermann C, Braff M, Montgomery A. Microbiologic resistance and clinical efficacy of aztreonam lysine for inhalation (AZLI) in cystic fibrosis (CF) Journal of Cystic Fibrosis. 7: S36. DOI: 10.1016/S1569-1993(08)60138-1 |
0.356 |
|
2008 |
Oermann C, McCoy K, Retsch-Bogart G, Gibson R, Quittner A, Montgomery A. Effect of multiple aztreonam lysine for inhalation (AZLI) cycles on disease-related endpoints and safety in patients with cystic fibrosis (CF) and Pseudomonas aeruginosa (PA): Interim analysis of 12 month data Journal of Cystic Fibrosis. 7: S25. DOI: 10.1016/S1569-1993(08)60097-1 |
0.382 |
|
2007 |
McCoy K, Retsch-Bogart G, Oermann C, Gibson R, Montgomery A. 40* Aztreonam lysine for inhalation (AZLI) for CF patients with P. aeruginosa (PA) infection Journal of Cystic Fibrosis. 6: S10. DOI: 10.1016/S1569-1993(07)60033-2 |
0.355 |
|
2006 |
McCoy K, Shade DM, Irvin CG, Mastronarde JG, Hanania NA, Castro M, Anthonisen NR. Predicting episodes of poor asthma control in treated patients with asthma. The Journal of Allergy and Clinical Immunology. 118: 1226-33. PMID 17157651 DOI: 10.1016/J.Jaci.2006.09.006 |
0.319 |
|
2003 |
Ernst RK, D'Argenio DA, Ichikawa JK, Bangera MG, Selgrade S, Burns JL, Hiatt P, McCoy K, Brittnacher M, Kas A, Spencer DH, Olson MV, Ramsey BW, Lory S, Miller SI. Genome mosaicism is conserved but not unique in Pseudomonas aeruginosa isolates from the airways of young children with cystic fibrosis. Environmental Microbiology. 5: 1341-9. PMID 14641578 DOI: 10.1111/J.1462-2920.2003.00518.X |
0.34 |
|
2003 |
Varekojis SM, Douce FH, Flucke RL, Filbrun DA, Tice JS, McCoy KS, Castile RG. A comparison of the therapeutic effectiveness of and preference for postural drainage and percussion, intrapulmonary percussive ventilation, and high-frequency chest wall compression in hospitalized cystic fibrosis patients. Respiratory Care. 48: 24-8. PMID 12556258 |
0.324 |
|
2001 |
Rosenfeld M, Gibson RL, McNamara S, Emerson J, Burns JL, Castile R, Hiatt P, McCoy K, Wilson CB, Inglis A, Smith A, Martin TR, Ramsey BW. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatric Pulmonology. 32: 356-66. PMID 11596160 DOI: 10.1002/Ppul.1144 |
0.401 |
|
2001 |
Burns JL, Gibson RL, McNamara S, Yim D, Emerson J, Rosenfeld M, Hiatt P, McCoy K, Castile R, Smith AL, Ramsey BW. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. The Journal of Infectious Diseases. 183: 444-52. PMID 11133376 DOI: 10.1086/318075 |
0.404 |
|
2000 |
Castile R, Filbrun D, Flucke R, Franklin W, McCoy K. Adult-type pulmonary function tests in infants without respiratory disease. Pediatric Pulmonology. 30: 215-27. PMID 10973040 DOI: 10.1002/1099-0496(200009)30:3<215::Aid-Ppul6>3.0.Co;2-V |
0.326 |
|
1999 |
Rosenfeld M, Emerson J, Accurso F, Armstrong D, Castile R, Grimwood K, Hiatt P, McCoy K, McNamara S, Ramsey B, Wagener J. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatric Pulmonology. 28: 321-8. PMID 10536062 DOI: 10.1002/(Sici)1099-0496(199911)28:5<321::Aid-Ppul3>3.0.Co;2-V |
0.358 |
|
1998 |
Piedra PA, Poveda GA, Ramsey B, McCoy K, Hiatt PW. Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors. Pediatrics. 101: 1013-9. PMID 9606228 DOI: 10.1542/Peds.101.6.1013 |
0.351 |
|
1996 |
McCoy K, Hamilton S, Johnson C. Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease Chest. 110: 889-895. PMID 8874241 DOI: 10.1378/Chest.110.4.889 |
0.378 |
|
1996 |
Wilmott RW, Amin RS, Colin AA, DeVault A, Dozor AJ, Eigen H, Johnson C, Lester LA, McCoy K, McKean LP, Moss R, Nash ML, Jue CP, Regelmann W, Stokes DC, et al. Aerosolized recombinant human DNase in hospitalized cystic fibrosis patients with acute pulmonary exacerbations. American Journal of Respiratory and Critical Care Medicine. 153: 1914-7. PMID 8665055 DOI: 10.1164/Ajrccm.153.6.8665055 |
0.377 |
|
1985 |
Zipf WB, McCoy K, O'Dorisio T. 757 PRIMARY PANCREATIC POLYPEPTIDE (PP) DEFICIENCY IN CHILDREN WITH CYSTIC FIBROSIS Pediatric Research. 19: 237A-237A. DOI: 10.1203/00006450-198504000-00787 |
0.36 |
|
Show low-probability matches. |